QOF database

Home | News | Downloads
Betsi Cadwaladr University Health Board > MEDDYGFA HAFAN

MEDDYGFA HAFAN

DOC FICTORIA, CAERNARFON

HF004W

In those patients with a current diagnosis of heart failure due to left ventricular systolic dysfunction who are currently treated with an ACE-I or ARB, the percentage of patients who are additionally currently treated with a beta-blocker licensed for heart failure.

IndicatorYearNumeratorDenominatorRatioCentile
HF 4 2010 16 18 88.9%
HF 4 2011 18 20 90.0%
HF 4 2012 17 18 94.4%
HF 4 2013 19 21 90.5%
HF004W 2014 1 1 100.0%
HF004 2015 1 1 100.0%